This suggests that the COOH-terminal PRR of GRP78 is crucial for its interaction with CD44v at the cell surface and enforcing its expression may offer a new strategy for reducing tamoxifen-resistant breast cancer cell survival. This evidence concerns the gene HSPA5 and breast carcinoma.